AC Immune (ACIU) Goodwill & Intangibles (2021 - 2026)
AC Immune (ACIU) posted quarterly Goodwill & Intangibles of $64.4 billion for Q1 2026, up 114712.68% year-over-year from N/an in Q1 2025, and up 2.06% quarter-over-quarter from $63.1 billion in Q4 2025.
Analysis
AC Immune (ACIU) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Goodwill & Intangibles for 6 consecutive years, with $64.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 114712.68% year-over-year to $64.4 billion; the TTM figure through Mar 2026 stood at $64.4 billion (up 114712.68% YoY), while the FY2025 annual figure was $60.8 billion, up 105559.69% from the prior year.
- Goodwill & Intangibles improved to $64.4 billion in Q1 2026 per ACIU's latest filing, from $63.1 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $64.4 billion in Q1 2026 and bottomed at $52.2 million in Q3 2022.
- Historically, Goodwill & Intangibles has averaged $17.2 billion across 5 years, with a median of $57.8 million in 2024.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles slumped 99.9% — and 2026, when it surged 114712.68%.
- AC Immune's Goodwill & Intangibles stood at $52.3 million in 2022, then surged by 108506.04% to $56.8 billion in 2023, then plunged by 99.9% to $57.6 million in 2024, then jumped by 109505.42% to $63.1 billion in 2025, then rose by 2.06% to $64.4 billion in 2026.
- Business Quant data shows ACIU's Goodwill & Intangibles at $64.4 billion in Q1 2026, $63.1 billion in Q4 2025, and $63.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.79 Mn |
| Mar 31, 2026 | 64.38 Mn |
| Dec 31, 2025 | 63.08 Mn |
| Sep 30, 2025 | 63.03 Mn |
| Jun 30, 2025 | 60.90 Mn |
| Mar 31, 2025 | 56.08 Mn |
| Dec 31, 2024 | 57.55 Mn |
| Sep 30, 2024 | 58.19 Mn |
| Jun 30, 2024 | 55.75 Mn |
| Mar 31, 2024 | 57.76 Mn |
| Dec 31, 2023 | 56.84 Mn |
| Sep 30, 2023 | 57.08 Mn |
| Jun 30, 2023 | 56.07 Mn |
| Mar 31, 2023 | 54.51 Mn |
| Dec 31, 2022 | 52.33 Mn |
| Sep 30, 2022 | 52.20 Mn |
| Jun 30, 2022 | 52.35 Mn |
| Mar 31, 2022 | 54.59 Mn |
| Dec 31, 2021 | 54.68 Mn |